FEMA CHIEF CONDEMNS MISINFORMATION FOLLOWING HURRICANE HELENE
The U.S. government’s top disaster relief official criticized false claims and conspiracy theories surrounding the federal response to Hurricane Helene, stating they are “demoralizing” aid workers and instilling fear in those needing assistance. Deanne Criswell, the head of FEMA, condemned the rhetoric, particularly from Donald Trump and other Republicans, which falsely suggests that aid is being withheld from Republican areas. Criswell emphasized that FEMA has sufficient funds for the Helene response, supported by a recent congressional allocation of $20 billion. Misinformation has spread, including extreme theories about land seizures and weather control technology, which have fostered mistrust among affected communities. President Joe Biden affirmed his administration’s commitment to collaborating with local leaders, regardless of political affiliation. Meanwhile, FEMA is preparing for Hurricane Milton, which has recently intensified and is headed toward Florida, ensuring that state requirements are addressed ahead of landfall. (AP)
NASA FINALIZES PLANS FOR LOW-EARTH ORBIT OPERATIONS POST-2030
The upcoming year is critical for NASA as it navigates its future plans for human activity in low-Earth orbit (LEO). Facing the possibility of not having any crew members in orbit, NASA is finalizing a strategy for operations beyond 2030 and intends to award contracts to private companies for the development of small space stations, shifting from operators to customers. NASA’s deputy administrator, Pam Melroy, emphasized the importance of continuing research in microgravity, particularly for long-duration missions like those to Mars. Despite previous investments in commercial space station development, challenges have arisen, including financial difficulties for key companies like Axiom Space. While NASA is preparing for potential gaps in LEO presence, there is uncertainty about market demand for private stations and whether commercial companies can effectively capitalize on this. Ultimately, NASA must commit to supporting these ventures to ensure the development of safe and functional habitats in space, as the transition from the International Space Station is imminent. (Ars Technica)
RWANDA FACES MARBURG VIRUS OUTBREAK WITH LIMITED RESOURCES
Rwanda’s health care system is at risk of being overwhelmed by the Marburg virus, which has already infected over 42 individuals, predominantly medical professionals, resulting in at least 13 deaths. The outbreak began in late September, marking Rwanda’s first encounter with the virus. Among the infected are two of the country’s few anesthesiologists, putting further strain on an already limited medical workforce. Health Minister Dr. Sabin Nsanzimana has stated that the country is seeking experimental vaccines and treatments to combat the outbreak. Marburg, related to Ebola, is transmitted through contact with infected bodily fluids and has a high fatality rate. Initial symptoms resemble those of malaria, complicating diagnosis. The outbreak reportedly started when a man infected several relatives, leading to transmission within King Faisal Hospital, which has the highest number of cases. Although potential vaccines are in early trials, none are yet available, presenting significant challenges in managing the outbreak effectively. (New York Times)
CHINESE HACKERS INVADE US TELECOM FIRMS IN ESPIONAGE ATTACK
A skilled group of Chinese government-linked hackers has reportedly infiltrated several U.S. telecommunications firms, including AT&T, Verizon, and Lumen, in a likely effort to obtain sensitive national security information. U.S. investigators believe the hackers may have accessed wiretap warrant requests, but it is still unclear what specific data was compromised. This incident highlights ongoing tensions between the U.S. and China regarding cyber-espionage and national security issues. Telecom companies hold vast amounts of user data that law enforcement agencies often request for investigations, making them prime targets for espionage. The Chinese Embassy in Washington has denied involvement, claiming the accusations distort the facts. Cybersecurity experts, including those from Microsoft and Mandiant, have noted the hackers’ skill and persistence, identifying the group as Salt Typhoon. U.S. officials have briefed Congress about the hacking campaign, which is part of a broader pattern of Chinese cyber intrusions that includes targeting U.S. transportation and communications networks, as well as breaching the unclassified email accounts of senior diplomats. (CNN)
MILLIONS INVESTED TO IMPROVE IMMUNOTHERAPY CANCER OUTCOMES
Alex Green, a melanoma survivor, credits immunotherapy with saving his life after his cancer returned in 2019. Despite its life-changing benefits, many cancer patients experience no improvement from this treatment, with some suffering severe side effects, such as painful inflammation in various organs. In response, a multimillion-pound research program aims to understand why at least half of patients fail to respond to immunotherapy or endure debilitating side effects. The project, involving 16 academic institutions and 12 bioscience companies, will study biomarkers that can indicate a patient’s likelihood of benefiting from immunotherapy. This could lead to more personalized treatments and potentially new therapies, such as vaccines. The study will include 3,000 patients who have completed treatment and another 3,000 beginning treatment across various cancer types. Led by Professor Samra Turajlic at the Francis Crick Institute, the initiative is supported by £9 million from government health organizations and £12.9 million from industry. This research is part of a broader £145 million commitment to enhance cancer diagnosis and treatment in the UK, aiming to improve outcomes for countless families affected by the disease. (BBC)
J&J DEPRIORITIZES DENGUE VACCINE AMIDST STRATEGIC RESTRUCTURING
Johnson & Johnson (J&J) has decided to deprioritize its dengue virus vaccine, mosnodenvir, amidst a broader shift in its infectious disease pipeline. This decision follows last year’s merger of J&J’s infectious disease and vaccine operations, which resulted in the cancellation of several projects, including a late-stage respiratory syncytial virus program and the sale of an E. coli vaccine to Sanofi. Despite experiencing challenges in clinical trials, mosnodenvir demonstrated promise in October 2023, showing a dose-dependent antiviral effect against dengue virus serotype 3 in a phase 2 trial. However, J&J announced the discontinuation of a follow-up phase 2 field study, citing a “strategic reprioritization” of its research and development portfolio, with no safety concerns identified. J&J remains committed to combating dengue and plans to share study results with the medical community. The company has been investing in dengue research for over a decade, including establishing a Satellite Center for Global Health Discovery in Singapore. (Fierce Biotech)
NASA EXPLORES NUCLEAR PROPULSION FOR FASTER MARS MISSIONS
NASA is planning crewed missions to Mars within the next decade, but the journey could take several months to years due to reliance on traditional chemical rocket fuel. To address this, NASA is exploring nuclear thermal propulsion (NTP), which utilizes nuclear fission to significantly reduce travel time. NTP could potentially enable a rocket to make the Mars trip in half the time compared to chemical propulsion systems. Currently, NASA and the Defense Advanced Research Projects Agency (DARPA) are jointly developing NTP technology, with plans to demonstrate a prototype in space by 2027. Unlike chemical rockets that rely on combustion of propellants, NTP heats propellants using nuclear reactions, yielding higher thrust and efficiency. Historically, U.S. efforts on NTP were curtailed due to safety and proliferation concerns surrounding highly enriched uranium. The current focus is on high-assay, low-enriched uranium (HALEU) fuel, aiming to optimize performance while ensuring safety. Researchers, including those from Georgia Tech, are developing models and simulations to refine NTP designs for future missions. (The Conversation US)
Thanks for reading. Let’s be careful out there.
WORDS: The Biology Guy.
IMAGE CREDIT: Polly Irungu.